Pharmaceutical MRO data quality has a different risk profile from ordinary inventory cleanup. Duplicate records inflate stock and slow search, but careless consolidation can create quality and validation risk if equipment context, material specification, or documentation history is lost.
The catalog often grows through equipment qualification, production-line changes, clean-utility maintenance, laboratory assets, site autonomy, and ERP migration. The same part may appear under multiple item numbers because each record was created for a valid operational reason at a different point in time.
PartsCleanse AI is designed to keep the diagnostic bounded. It identifies likely duplicate families, applies discriminator penalties for critical specification conflicts, and presents findings as a governed review backlog rather than an automatic cleanup instruction.
For pharmaceutical leadership, the report creates a measurable starting point: capital exposure, duplicate-family evidence, confidence tiers, and the operating language needed for maintenance, engineering, quality, procurement, and finance to align on next actions.
